| Quarterly Financials | Jun 2018 | Sept 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sept 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sept 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
Revenue  | 16 | 15 | 12 | 17 | 13 | 14 | 16 | 16 | 7 | 16 | 17 | 19 | 16 | 19 | 20 | 18 | 18 | 19 | 19 | 20 | 23 | 21 | 24 | 22 | 26 | 26 | 26 | 31 | 33 |
| Expenses | 15 | 14 | 13 | 15 | 13 | 14 | 15 | 15 | 8 | 15 | 16 | 17 | 14 | 18 | 18 | 16 | 15 | 17 | 19 | 20 | 21 | 21 | 25 | 22 | 25 | 26 | 27 | 34 | 32 |
| EBITDA | 1 | 1 | -1 | 3 | 1 | -0 | 1 | 1 | -1 | 1 | 2 | 2 | 1 | 1 | 2 | 2 | 3 | 2 | -0 | -0 | 2 | 0 | -0 | 1 | 1 | 0 | -1 | -3 | 1 |
| Operating Profit % | 4 % | 4 % | -7 % | 2 % | 3 % | -2 % | 7 % | 5 % | -12 % | 4 % | 7 % | 2 % | 8 % | 3 % | 8 % | 9 % | 15 % | 8 % | -0 % | -2 % | 6 % | -1 % | -3 % | 0 % | 4 % | -0 % | -4 % | -9 % | 2 % |
| Depreciation | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 1 |
| Profit Before Tax | -0 | -0 | -2 | 1 | -1 | -1 | -0 | -0 | -2 | -0 | -0 | 1 | 0 | -0 | 1 | 1 | 2 | 1 | -1 | -2 | 1 | -1 | -1 | -1 | 0 | -1 | -2 | -4 | -1 |
| Tax | -0 | 0 | 0 | -1 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | 0 | 0 | 0 | -0 | -0 | 0 | 0 | -0 | 0 | 0 | 0 | 0 | -0 | 0 | 0 | 0 | 0 |
| Net Profit | -0 | -0 | -2 | 2 | -1 | -1 | 0 | -0 | -2 | -0 | 0 | 1 | 0 | -0 | 1 | 1 | 2 | 1 | -1 | -2 | 1 | -1 | -1 | -1 | 0 | -1 | -2 | -4 | -1 |
| EPS in ₹ | -1.16 | -0.56 | -4.46 | 2.96 | -1.55 | -2.59 | 0.01 | -0.66 | -3.68 | -0.50 | 0.16 | 2.23 | 0.27 | -0.67 | 1.63 | 1.29 | 3.84 | 1.68 | -2.05 | -3.80 | 1.04 | -2.32 | -2.48 | -1.81 | -0.50 | -2.41 | -4.03 | -7.03 | -2.02 |
GKB Ophthalmics
GKB Ophthalmics
69.38
+0.27
(0.39%)
There are new updates from the company18 hours ago
View
Market Cap
35.00 Cr
EPS
-13.98
PE Ratio
-
Dividend Yield
0.00 %
Industry
Healthcare52 Week High
113.80
52 Week Low
59.00
PB Ratio
0.67
Debt to Equity
0.23
Sector
Medical Equipment
Investment Returns
In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Company News
View All News
GKB Ophthalmics Limited received a proposal from its material subsidiary GSV Ophthalmics Private Limited to initiate voluntary liquidation under the Insolvency and Bankruptcy Code, 2016. The Board of Directors reviewed and approved the proposal on September 22, 2025. GSV has had no business operations since inception and earns passive income through interest on fixed deposits and loans advanced to GKB Ophthalmics. The subsidiary holds Rs. 5.00 crores in unsecured loans to the parent company and contributed Rs. 1.16 crores in total income (1.05% of consolidated income) and Rs. 16.21 crores in net worth (28.72% of consolidated net worth) as of March 31, 2025. The liquidation will primarily impact consolidated financials through reduced other income from interest on fixed deposits. GKB Ophthalmics will seek shareholder approval through postal ballot with a cut-off date of September 26, 2025. The company expects to recover its 79.54% equity investment after liquidation costs are deducted.
GKB Ophthalmics Limited received an order from the Labour Commissioner directing recovery of Rs 8,82,00,856 related to ongoing litigation with its workmen. The dispute stems from a 2009 case filed by the Goa Trade & Commercial Workers' Union for adjudication of Charter of Demands, where an Industrial Tribunal passed an award on May 25, 2021. The company is challenging the original award through a writ petition in the High Court of Bombay at Goa, arguing that factors like industry standards, regional formulas, and the company's financial position were not considered. GKB Ophthalmics disputes the liability and plans to challenge the Labour Commissioner's recovery order in the High Court. The company states the order is likely to have a material impact on its financial position.
Vijay Kedia Backs Investor's Criticism of GKB Ophthalmics Management Despite Condemning Language Used
Aug 25, 2025
Aug 25, 2025Ace investor Vijay Kedia responded to a viral incident at GKB Ophthalmics Ltd's virtual annual general meeting where shareholder Abhishek Kalra, owning just one share, launched a verbal attack on the company's management. Kalra criticized Managing Director Krishna Gopal Gupta over poor stock performance and governance issues, demanding his resignation within 10 days. While Kedia condemned the harsh language used by the investor, he supported the underlying message that shareholder money must be respected. Kedia emphasized that incompetent managements with high salaries and perks should recognize that India's 13 crore investors have their own ways of expressing dissatisfaction with corporate performance.
View more
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
1,959.50 | #1 19,854.80 | 55.48 | #1 1,759.00 | 22.62 | #1 339 | 25.81 | 52.54 | |
316.90 | 1,741.80 | 75.37 | 242.40 | 24.12 | 25 | -50.60 | 39.40 | |
307.25 | 1,634.80 | 59.23 | 408.40 | 32.64 | 30 | -55.00 | 32.63 | |
615.20 | 1,022.60 | 62.71 | 249.37 | 40.00 | 17 | -20.59 | 50.33 | |
618.35 | 997.30 | 49.75 | 186.60 | 40.62 | 20 | - | 66.47 | |
550.00 | 660.20 | 34.94 | 67.10 | 13.15 | 18 | 18.92 | 44.24 | |
284.20 | 541.10 | #1 33.59 | 136.30 | #1 107.77 | 16 | - | 69.40 | |
325.35 | 339.70 | 42.92 | 111.80 | -1.43 | 8 | -0.10 | 61.49 | |
278.00 | 292.30 | 36.53 | 89.85 | 0.60 | 7 | #1 752.54 | 56.11 | |
228.34 | 228.30 | - | 122.10 | 19.24 | 1 | -52.94 | 34.78 |
Forecast
Actual
Growth Rate
Revenue Growth
22.83 %
Net Income Growth
136.67 %
Cash Flow Change
-181.28 %
ROE
170.26 %
ROCE
441.41 %
EBITDA Margin (Avg.)
-156.90 %
Quarterly Financial Results
Balance Sheet
| Balance Sheet | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Total Assets | 75 | 69 | 82 | 83 | 93 | 102 | 107 | 110 | 112 | 115 | 125 |
| Fixed Assets | 12 | 13 | 18 | 18 | 26 | 26 | 24 | 23 | 19 | 18 | 17 |
| Current Assets | 46 | 51 | 63 | 64 | 64 | 73 | 74 | 76 | 84 | 88 | 99 |
| Capital Work in Progress | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 3 | 4 | 4 | 4 |
| Investments | 0 | 6 | 4 | 0 | 1 | 1 | 2 | 2 | 2 | 2 | 2 |
| Other Assets | 63 | 50 | 60 | 64 | 67 | 75 | 80 | 82 | 87 | 91 | 102 |
| Total Liabilities | 75 | 69 | 82 | 83 | 93 | 102 | 107 | 110 | 112 | 115 | 125 |
| Current Liabilities | 33 | 23 | 33 | 36 | 37 | 41 | 38 | 39 | 41 | 46 | 62 |
| Non Current Liabilities | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 4 | 4 | 4 | 6 |
| Total Equity | 40 | 45 | 47 | 45 | 55 | 59 | 66 | 67 | 67 | 64 | 56 |
| Reserve & Surplus | 36 | 41 | 43 | 41 | 47 | 54 | 58 | 58 | 58 | 55 | 47 |
| Share Capital | 4 | 4 | 4 | 4 | 5 | 5 | 5 | 5 | 5 | 5 | 5 |
Cash Flow
| Cash Flow | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Net Cash Flow | 1 | 0 | -1 | 0 | 7 | 4 | -7 | -0 | -4 | 1 | -0 |
| Investing Activities | -1 | 15 | 4 | 1 | -10 | -4 | -17 | -4 | 1 | -2 | 3 |
| Operating Activities | 7 | -11 | -3 | -3 | 4 | 3 | 7 | 5 | -3 | 4 | -3 |
| Financing Activities | -6 | -3 | -1 | 1 | 13 | 4 | 3 | -2 | -2 | -2 | 1 |
Share Holding
| % Holding | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
| Promoter | 59.44 % | 59.24 % | 59.58 % | 59.69 % | 59.72 % | 59.73 % | 59.16 % | 59.09 % | 59.09 % | 59.18 % | 50.86 % | 50.88 % | 50.93 % | 50.95 % | 50.95 % | 50.98 % | 50.99 % | 51.06 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 1.79 % | 1.79 % | 1.79 % | 1.79 % | 1.79 % | 1.79 % | 1.79 % | 1.79 % |
| DIIs | 0.39 % | 0.39 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.01 % | 0.01 % | 0.01 % | 0.01 % | 0.01 % | 0.01 % | 0.01 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 23.93 % | 24.44 % | 24.90 % | 24.48 % | 24.63 % | 24.79 % | 24.82 % | 24.79 % | 27.11 % | 27.40 % | 36.01 % | 36.04 % | 36.04 % | 36.64 % | 36.34 % | 36.96 % | 37.36 % | 37.22 % |
| Others | 16.24 % | 15.93 % | 15.52 % | 15.83 % | 15.65 % | 15.47 % | 16.01 % | 16.11 % | 13.79 % | 13.41 % | 11.34 % | 11.28 % | 11.23 % | 10.63 % | 10.93 % | 10.27 % | 9.87 % | 9.94 % |
| No of Share Holders | 1,185 | 1,545 | 1,430 | 1,434 | 1,432 | 1,443 | 1,443 | 1,637 | 1,933 | 2,030 | 2,115 | 2,233 | 2,370 | 2,690 | 2,510 | 2,539 | 2,538 | 2,550 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 20 Aug 2024 |  Annual General Meeting | NA | 20 Aug 2024 | 87.04 | 108.60 |
| 14 Nov 2024 |  Quarterly Result Announcement | NA | 14 Nov 2024 | 100.80 | 99.65 |
| 13 Feb 2025 | Quarterly Result Announcement | NA | 13 Feb 2025 | 90.18 | 89.12 |
| 30 May 2025 | Quarterly Result Announcement | NA | 30 May 2025 | 69.80 | 73.00 |
| 14 Aug 2025 | Quarterly Result Announcement | NA | 14 Aug 2025 | 76.35 | 74.99 |
| 21 Aug 2025 | Annual General Meeting | NA | 21 Aug 2025 | 73.00 | 79.91 |
Announcements
Closure of Trading Window18 hours ago
18 hours agoIntimation And Board Outcome Regarding Voluntary Liquidation Of Material Subsidiary - GSV Ophthalmics Private Limited - September 22 2025.5 days ago
5 days agoClosure of Trading Window10 days ago
10 days agoSubmission Of Minutes Of 43Rd Annual General Meeting Of The Company Held On 21St August 2025Sep 16, 2025
Sep 16, 2025Receipt Of Order - Update On Case No. 32/09 Filed For Adjudication Of Charter Of DemandsSep 12, 2025
Sep 12, 2025Scrutinizers Report - Voting Results Of Annual General Meeting Held On August 21 2025.Aug 22, 2025
Aug 22, 2025Shareholder Meeting / Postal Ballot-Outcome of AGMAug 21, 2025
Aug 21, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 19, 2025
Aug 19, 2025Corrigendum To The Annual Report For The Financial Year 2024-2025.Aug 16, 2025
Aug 16, 2025GKB Ophthalmics Limited - Unaudited Standalone & Consolidated Financial Results - June 30 2025Aug 14, 2025
Aug 14, 2025Board Meeting Outcome for Outcome Of Board Meeting Of GKB Ophthalmics Limited Held On August 14 2025Aug 14, 2025
Aug 14, 2025Board Meeting Intimation for Board Meeting For Approval Of Unaudited Financial Results For The Quarter Ended June 30 2025.Jul 31, 2025
Jul 31, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 30, 2025
Jul 30, 2025Reg. 34 (1) Annual Report.Jul 29, 2025
Jul 29, 2025Notice For Book ClosureJul 28, 2025
Jul 28, 2025GKB Ophthalmics Limited- Submission Of Annual Report For The Financial Year 2024-25Jul 28, 2025
Jul 28, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 16, 2025
Jul 16, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 10, 2025
Jul 10, 2025Board Meeting Outcome for Disclosure Under Regulation 30 SEBI (LODR) Regulations 2015 - Outcome Of Board Meeting Of The Company Held On July 09 2025Jul 09, 2025
Jul 09, 2025Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations 2015Jun 30, 2025
Jun 30, 2025Closure of Trading WindowJun 27, 2025
Jun 27, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationJun 02, 2025
Jun 02, 2025GKB- Audited Standalone And Consolidated Financial Results For The Quarter And Year Ended March 31 2025May 30, 2025
May 30, 2025Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 30, 2025
May 30, 2025Board Meeting Outcome for Outcome Of The Board Meeting Held On May 30 2025May 30, 2025
May 30, 2025Board Meeting Intimation for Approval Of Audited Standalone And Consolidated Financial Results For The Quarter And Year Ended March 31 2025May 14, 2025
May 14, 2025Intimation Of Change In Contact Details Of Registrar And Share Transfer Agent ("RTA") Of The CompanyApr 21, 2025
Apr 21, 2025Non Applicability Of Circular No. SEBI/HO/DDHS/CIR/P/2018/144 Dated November 26 2018.Apr 10, 2025
Apr 10, 2025Announcement under Regulation 30 (LODR)-Credit RatingApr 09, 2025
Apr 09, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 08, 2025
Apr 08, 2025Disclosure Under Regulations 31 (4) Of SEBI (Substantial Acquisition Of Shares And Takeover) Regulations 2011 For The Financial Year Ended On March 31 2025.Apr 02, 2025
Apr 02, 2025Intimation Under Regulation 30 Of SEBI( Listing Obligations And Disclosure Requirements) Regulation 2015- Completion Of Tenure Of Independent Director And Re- Constitution Of Committees Of The Board.Mar 31, 2025
Mar 31, 2025Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations 2015Mar 31, 2025
Mar 31, 2025Closure of Trading WindowMar 29, 2025
Mar 29, 2025Outcome Of Independent Directors Meeting Held On March 27 2025.Mar 27, 2025
Mar 27, 2025Notice Of The Independent Directors MeetingMar 18, 2025
Mar 18, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 19, 2025
Feb 19, 2025Integrated Filing (Financial)Feb 13, 2025
Feb 13, 2025GKB- Unaudited Standalone And Consolidated Financial Results For The Quarter And Nine Months Ended December 31 2024Feb 13, 2025
Feb 13, 2025Board Meeting Outcome for Outcome Of The Board Meeting Of GKB Ophthalmics Limited Held On February 13 2025Feb 13, 2025
Feb 13, 2025GKB Ophthalmics Limited Integrated Filling(Governance) For The Quarter Ended December 31 2024Feb 06, 2025
Feb 06, 2025Board Meeting Intimation for Consider And Take On Record The Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter And Nine Months Ended December 31 2024.Jan 24, 2025
Jan 24, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 09, 2025
Jan 09, 2025Change In Name Of Registrar And Share Transfer Agent("RTA")Jan 09, 2025
Jan 09, 2025Outcome Of The Board Meeting Held On January 03 2025 And Execution Of Loan AgreementJan 03, 2025
Jan 03, 2025Sanctioning Of Loan Amount Of Rs. 5.00 Crores By Subsidiary Company To GKB Ophthalmics Limited Holding Company.Jan 02, 2025
Jan 02, 2025Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations 2015Dec 31, 2024
Dec 31, 2024Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations 2015Dec 31, 2024
Dec 31, 2024Closure of Trading WindowDec 27, 2024
Dec 27, 2024Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations, 2015Dec 04, 2024
Dec 04, 2024Technical Indicators
RSI(14)
Neutral 40.12
ATR(14)
Less Volatile 4.04
STOCH(9,6)
Oversold 7.78
STOCH RSI(14)
Oversold 12.84
MACD(12,26)
Bearish -0.28
ADX(14)
Strong Trend 29.11
UO(9)
Bearish 38.56
ROC(12)
Downtrend And Accelerating -4.54
WillR(14)
Oversold -88.41
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
